From: Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography
Group | Total | Low risk | Intermediate risk | High risk |
---|---|---|---|---|
Number | 160 | 113 | 15 | 32 |
Age | 52.46 ± 17.81 | 51.76 ± 18.84 | 54.87 ± 14.28 | 53.78 ± 15.64 |
Sex (M/F) | 91/69 | 55/58 | 7/8 | 29/3 |
Pre-SCr (mg/dL) | 1.52 ± 1.31 | 0.90 ± 0.27 | 1.60 ± 0.11 | 3.64 ± 1.59 |
Post-SCr (mg/dL) | 1.51 ± 1.28 | 0.93 ± 0.32 | 1.63 ± 0.26 | 3.53 ± 1.60 |
p value | 0.93 | 0.13 | 0.65 | 0.04* |
Pre-eGFR (mL/min/1.73 m2) | 67.02 ± 36.62 | 84.47 ± 29.71 | 41.81 ± 6.77 | 21.56 ± 8.81 |
Post-eGFR (mL/min/1.73 m2) | 66.41 ± 36.54 | 83.23 ± 30.69 | 41.36 ± 6.76 | 22.93 ± 10.47 |
p value | 0.54 | 0.37 | 0.81 | 0.08 |